Alzheimer'S And Medications

Alzheimer's disease, a progressive neurological disorder, poses significant challenges in treatment. Medications for Alzheimer's primarily aim to manage symptoms rather than cure the disease. Cholinesterase inhibitors such as donepezil, rivastigmine, and galantamine are commonly prescribed to enhance communication among brain cells by preserving acetylcholine, a neurotransmitter critical for memory and learning. Another class of drugs, NMDA receptor antagonists like memantine, regulates glutamate activity to moderate symptoms.

However, these medications only offer temporary relief from cognitive decline and do not halt the disease's progression. They may alleviate symptoms such as memory loss, confusion, and changes in behavior, providing patients and caregivers with improved quality of life in the early to moderate stages of Alzheimer's. Research into new treatments continues to explore novel approaches, but current therapies underscore the need for holistic care strategies that encompass medication, therapy, and support services for both patients and their families.